“We selected Dublin as our European HQ because of the available talent pool of well-qualified and highly-educated people. We have further expanded our business in Ireland because of the success we have had doing business in Ireland.”
Mr. Vincent Viola, Founder and Chairman of Virtu
– Taoiseach Enda Kenny today announced the opening of the Virtu Financial, LLC (“Virtu”), European HQ in Dublin and the creation of 30 highly skilled jobs for graduates in the fields of mathematics, computer science and other sciences (including those graduates holding Masters or Doctorate degrees). Virtu Financial is one of the world's leading electronic trading and market making firms. The Headquarters are to be officially opened this evening by An Taoiseach, Mr. Enda Kenny.
Virtu is an electronic market maker on numerous exchanges and electronic marketplaces in equities, fixed income, currencies and commodities. Since 2005, Virtu has leveraged cutting edge technology to grow its market share across multiple asset classes and markets, playing a vital role in contributing to the health and efficiency of global financial markets.
Virtu has consolidated all of its European business into the Dublin office, which is located at Sir John Rogerson’s Quay. Virtu is a new breed of electronic trading firms that provide market making services across all European markets through the use of sophisticated technology. Virtu also has offices in New York, Austin and Singapore.
A patient dies, and Elan stock takes dive
The share price of one of Ireland's biggest companies collapsed on Monday, in a move that sent tremors through financial markets on both sides of the Atlantic. Elan saw $7 billion knocked off its value in a single day's trading after the company and its partner, Biogen, suspended sales of their new drug, Tysabri, following the death of a patient
The patient died after developing a rare brain and spinal cord infection called progressive multifocal leukoencephalopathy. Another case of the disease is suspected.
Tysabri is used to treat multiple sclerosis. It was launched with considerable fanfare in November, and had been expected to reinvigorate Elan's fortunes